Preview Mode Links will not work in preview mode

Sep 22, 2026

Featuring perspectives from Dr David W Cescon, including the following topics:

  • Clinical treatment of BRCA-mutated metastatic triple-negative breast cancer (0:00)
  • CNS activity of TROP2-directed antibody-drug conjugates (5:36)
  • Autoimmune considerations with immunotherapy (10:09)
  • Treatment of oligoprogressive advanced breast cancer (17:31)

CME information and select publications